Endothelial Cells at Inflammatory Sites as Target for Therapeutic Intervention

References

• Adler R., Hurwitz E., Wands J.R., Sela M., and Shouval D. (1995) Speciactargeting of adriamycin conjugates with monoclonal antibodies to hepatoma associated antigens to intrahepatic tumors in athymic mice. Hepatology, 22, 1482–1487.
   Google Scholar
• Allen T.M.. (1997) Liposomes: Opportunities in drug delivery. Drugs, 54, 8–14.
   Google Scholar
• Allen T.M., Hansen C, Martin F, Redemann C, and Yau Young A. (1991) Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochimica et Biophysica Acta, 1066, 29–36.
   Google Scholar
• Almenar-Queralt A., Duperray A, Miles L.A., Felez J, and Altieri D.C.. (1995) Apical topography and modulation of ICAM-1 expression on activated endothelium. American Journal of Pathology, 147, 1278–1288.
   PubMed Web of Science ®Google Scholar
• Arap W., Pasqualini R., and Ruoslahti E. (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science, 279, 377–380.
   PubMed Web of Science ®Google Scholar
• Bendas G., Krause A., Schmidt R., Vogel J., and Rothe U. (1998) Selectins as new targets for immunoliposome-mediated drug delivery. A potential way of anti-in?ammatory therapy. Pharmaceutica Acta Helvetica, 73, 19–26.
   PubMedGoogle Scholar
• Bennett C.F., Condon T.P., Grimm S., Chan H., and Chiang M.Y. (1994) Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. Journal of Immunology, 152, 3530–3540.
   PubMed Web of Science ®Google Scholar
• Bennett C.F., Kornbrust D., Henry S., Stecker K., Howard R., Cooper S., Dutson S., Hall W., and Jacoby H.I. (1997) An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. Journal of Pharmacology and Experimental Therapeutics, 280, 988–1000.
   PubMed Web of Science ®Google Scholar
• Bevilacqua M.P., Stengelin S., Gimbrone M.A.J., and Seed B. (1989) Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science, 243, 1160–1165.
   PubMed Web of Science ®Google Scholar
• Bloemen P.G.M., Henricks P.A., van Bloois L., van den Tweel M.C., Bloem A.C., Nijkamp F.P., Crommelin D.J.A., and Storm G. (1995) Adhesion molecules: A new target for immunoliposome-mediated drug delivery. FEBS Letters, 357, 140–144.
   PubMed Web of Science ®Google Scholar
• Bogen S., Pak J., Garifallou M., Deng X., and Muller W.A. (1994) Monoclonal antibody to murine PECAM-1 (CD31) blocks acute in?ammation in vivo. Journal of Experimental Medicine, 179, 1059–1064.
   PubMed Web of Science ®Google Scholar
• Bondeson J., Foxwell B., Brennan F., and Feldmann M. (1999) De?ning therapeutic targets by using adenovirus: Blocking NF-kappa B inhibits both in?ammatory and destructive mechanisms in rheumatoid synovium but spares anti-in?ammatory mediators. Proceedings of the National Academy of Sciences USA, 96, 5668–5673.
   PubMed Web of Science ®Google Scholar
• Boyle E.M.J., Kovacich J.C., Canty T.G.J., Morgan E.N., Chi E., Verrier E.D., and Pohlman T.H. (1998) Inhibition of nuclear factor-kappa B nuclear localization reduces human E-selectin expression and the systemic in?ammatory response. Circulation, 98, II282–II288.
   Google Scholar
• Brostjan C., Anrather J., Csizmadia V., Natarajan G., and Winkler H. (1997) Glucocorticoids inhibit E-selectin expression by targeting NF-kappa B and not ATF/c-Jun. Journal of Immunology, 158, 3836–3844.
   PubMed Web of Science ®Google Scholar
• Bullard D.C., Mobley J.M., Justen J.M., Sly L.M., Chosay J.G., Dunn C.J., Lindsey J.R., Beaudet A.L., and Staite N.D. (1999) Acceleration and increased severity of collagen-induced arthritis in P-selectin mutant mice. Journal of Immunology, 163, 2844–2849.
   PubMed Web of Science ®Google Scholar
• Cronstein B.N., Kimmel S.C., Levin R.I., Martiniuk F., and Weissmann G. (1992) A mechanism for the antiin?ammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proceedings of the National Academy of Sciences USA, 89, 9991–9995.
   PubMed Web of Science ®Google Scholar
• Everts M., Kok R.J., Asgeirsdottir S.A., Melgert B.N., Moolenaar T.J.M., Koning G.A., van Luyn M.J.A., Meijer D.K.F., and Molema G. (2002) Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin directed immunoconjugate. Journal of Immunology, 168, 883–889.
   PubMed Web of Science ®Google Scholar
• Fischer P.M., Krausz E., and Lane D.P. (2001) Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Bioconjugate Chemistry, 12, 825–841.
   PubMed Web of Science ®Google Scholar
• Fonseca M.J., Storm G., Hennink W.E., Gerritsen W.R., and Haisma H.J. (1999) Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin pro-drug therapy. Journal of Gene Medicine, 1, 407–414.
   PubMed Web of Science ®Google Scholar
• Foster C.A. (1996) VCAM-1/?4-integrin adhesion pathway: Therapeutic target for allergic in?ammatory disorders. Journal of Allergy and Clinical Immunology, 98, S270–S277
   Google Scholar
• Gallatin W.M., Weissman I.L., and Butcher E.C. (1984) A cell-surface molecule involved in organ-speci?c homing of lymphocytes. Nature, 304, 30–34.
   Web of Science ®Google Scholar
• Gerlag D.M., Borges E., Tak P.P., Ellerby H.M., Bredesen D.E., Pasqualini R., Ruoslahti E., and Firestein G.S. (2001) Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Research, 3, 357–361.
   PubMedGoogle Scholar
• Gregoriadis G. (1995) Engineering liposomes for drug delivery: Progress and problems. Trends in Biotechnology, 13, 527–537.
   PubMed Web of Science ®Google Scholar
• Grif?oen A.W., and Molema G. (2000) Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases and chronic in?ammation. Pharmacological Reviews, 52, 237–268.
   PubMed Web of Science ®Google Scholar
• Hamamoto N., Maemura K., Hirata I., Murano M., Sasaki S., and Katsu K. (1999) Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leukocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)). Clinical and Experimental Immunology, 117, 462–468.
   PubMed Web of Science ®Google Scholar
• Harari O.A., Wickham T.J., Stocker C.J., Kovesdi I., Segal D.M., Huehns T.Y., Sarraf C., and Haskard D.O. (1999) Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin. Gene Therapy, 6, 801–807.
   PubMed Web of Science ®Google Scholar
• Hartwell D.W., Mayadas T.N., Berger G., Frenette P.S., Rayburn H., Hynes R.O., and Wagner D.D. (1998) Role of P-selectin cytoplasmic domain in granular targeting in vivo and in early in?ammatory responses. Journal of Cell Biology, 143, 1129–1141.
   PubMed Web of Science ®Google Scholar
• Hennink W.E., and van Nostrum C.F. (2002) Novel crosslinking methods to design hydrogels. Advanced Drug Delivery Reviews, 54, 13–36.
   PubMed Web of Science ®Google Scholar
• Henricks P.A., and Nijkamp F.P. (1998) Pharmacological modulation of cell adhesion molecules. European Journal of Pharmacology, 344, 1–13.
   PubMed Web of Science ®Google Scholar
• Houck K.S., and Huang L. (1987) The role of multivalency in antibody mediated liposome targeting. Biochemical and Biophysical Research Communications, 145, 1205–1210.
   PubMed Web of Science ®Google Scholar
• Huang X., Molema G., King S., Watkins L., Edgington T.S., and Thorpe P.E. (1997) Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science, 275, 547–550.
   PubMed Web of Science ®Google Scholar
• Jackson J.R., Bolognese B., Hillegass L., Kassis S., Adams J., Griswold D.E., and Winkler J.D. (1998) Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic in?ammatory disease models. Journal of Pharmacology and Experimental Therapeutics, 284, 687–692.
   PubMed Web of Science ®Google Scholar
• Jackson J.R., Seed M.P., Kircher C.H., Willoughby D.A., and Winkler J.D. (1997) The codenpence of angiogenesis and chronic in?ammation. FASEB Journal, 11, 457–465.
   PubMed Web of Science ®Google Scholar
• Johnson B.A., Haines G.K., Harlow L.A., and Koch A.E. (1993) Adhesion molecule expression in human synovial tissue. Arthritis and Rheumatism, 36, 137–146.
   PubMed Web of Science ®Google Scholar
• Johnston B., Walter U.M., Issekutz A.C., Issekutz T.B., Anderson D.C., and Kubes P. (1997) Differential roles of selectins and the alpha4-integrin in acute, subacute, and chronic leukocyte recruitment in vivo. Journal of Immunology, 159, 4514–4523.
   PubMed Web of Science ®Google Scholar
• Kessner S., Krause A., Rothe U., and Bendas G. (2001) Investigation of the cellular uptake of E-selectin-targeted immunoliposomes by activated human endothelial cells. Biochimica et Biophysica Acta, 1514, 177–190.
   PubMed Web of Science ®Google Scholar
• Klimuk S.K., Semple S.C., Nahirney P.N., Mullen M.C., Bennett C.F., Scherrer P., and Hope M.J. (2000) Enhanced anti-in?ammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity. Journal of Pharmacology and Experimental Therapeutics, 292, 480–488.
   PubMed Web of Science ®Google Scholar
• Koch A.E., Burrows J.C., Haines G.K., Carlos T.M., Harlan J.M., and Leibovich S.J. (1991) Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues. Laboratory Investigation, 64, 313–320.
   PubMed Web of Science ®Google Scholar
• Kok R.J., Schraa A.J., Bos E.J., Moorlag H.E., Asgeirsdottir S.A., Everts M., Meijer D.K.F., and Molema G. (2002) Preparation and functional evaluation of RGD-modi?ed proteins as ?v? 3 integrin directed therapeutics. Bioconjugate Chemistry, 13, 128–135.
   PubMed Web of Science ®Google Scholar
• Koning G.A., Gorter A., Scherphof G.L., and Kamps J.A.A.M. (1999) Antiproliferative effect of immunoliposomes containing 5-?uorodeoxyuridinedipalmitate on colon cancer cells. British Journal of Cancer, 80, 1718–1725.
   PubMed Web of Science ®Google Scholar
• Koning G.A., Morselt H.W.M., Gorter A., Allen T.M., Zalipsky S., Kamps J.A.A.M., and Scherphof G.L. (2001) Pharmacokinetics of differently G. A. KONING ET AL. designed immunoliposome formulations in rats with or without hepatic colon cancer metastases. Pharmaceutical Research, 18, 1291–1298.
   PubMed Web of Science ®Google Scholar
• Koning G.A., Morselt H.W.M., Velinova M.J., Donga J., Gorter A., Allen T.M., Zalipsky S., Kamps J.A.A.M., and Scherphof G.L. (1999) Selective transfer of a lipophilic prodrug of 5-?uorodeoxyuridine (FUdR) from immunoliposomes to colon cancer cells. Biochimica et Biophysica Acta, 1420, 153–167.
   PubMed Web of Science ®Google Scholar
• Kraling B.M., and Bischoff J. (1998) A simpli?ed method for growth of human microvascular endothelial cells results in decreased senescence and continued responsiveness to cytokines and growth factors. In Vitro Cellular and Developmental Biology-Animal, 34, 308–315.
   PubMed Web of Science ®Google Scholar
• Kuijpers T.W., Raleigh M., Kavanagh T., Janssen H., Calafat J., Roos D., and Harlan J.M. (1994) Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. Journal of Immunology, 152, 5060–5069.
   PubMed Web of Science ®Google Scholar
• Kumar C.C. (1998) Signalling by integrin receptors. Oncogene, 17, 1365–1373.
   PubMed Web of Science ®Google Scholar
• Ley K. (1996) Molecular mechanisms of leukocyte recruitment in the in?ammatory process. Cardiovascular Research, 32, 733–742.
   PubMed Web of Science ®Google Scholar
• Mastrobattista E., Kapel R.H., Eggenhuisen M.H., Roholl P.J., Crommelin D.J., Hennink W.E., and Storm G. (2001) Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells. Cancer Gene Therapy, 8, 405–413.
   PubMed Web of Science ®Google Scholar
• Mastrobattista E., Koning G.A., and Storm G. (1999) Immunoliposomes for the targeted delivery of antitumor drugs. Advanced Drug Delivery Reviews, 40, 103–127.
   PubMed Web of Science ®Google Scholar
• Mastrobattista E., Storm G., van Bloois L., Reszka R., Bloemen P.G.M., Crommelin D.J.A., and Henricks P.A.J. (1999) Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells. Biochimica et Biophysica Acta, 1419, 353–363.
   PubMed Web of Science ®Google Scholar
• McMurray R.W. (1996) Adhesion molecules in autoimmune disease. Seminars in Arthritis and Rheumatism, 25, 215–233.
   PubMed Web of Science ®Google Scholar
• Michelson A.D., Barnard M.R., Hechtman H.B., MacGregor H., Connoly R.J., Loscalzo J., and Valeri C.R. (1996) In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proceedings of National Academy of Sciences USA, 93, 11877– 11882.
   PubMed Web of Science ®Google Scholar
• Moghimi S.M. (1995) Mechanisms of splenic clearance of blood cells and particles: Towards development of new splenotropic agents. Advanced Drug Delivery Reviews, 17, 103–115.
   Web of Science ®Google Scholar
• Mojcik C.F., and Shevach E.M. (1997) Adhesion molecules: A rheumatological perspective. Arthritis and Rheumatism, 40, 991–1004.
   PubMed Web of Science ®Google Scholar
• Monck M.A., Mori A., Lee D., Tam P., Wheeler J.J., Cullis P.R., and Scherrer P. (2000) Stabilized plasmid-lipid particles: Pharmacokinetics and plasmid delivery to distal tumors following intravenous injection. Journal of Drug Targeting, 7, 439–452.
   PubMed Web of Science ®Google Scholar
• Morris M.C., Depollier J., Mery J., Heitz F., and Divita G. (2001) A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nature Biotechnology, 19, 1173–1176.
   PubMed Web of Science ®Google Scholar
• Muller W.A., and Randolph G.J. (1999) Migration of leukocytes across endothelium and beyond: Molecules involved in the transmigration and fate of monocytes. Journal of Leukocyte Biology, 66, 698–704.
   PubMed Web of Science ®Google Scholar
• Murohara T., Margiotta J., Phillips L.M., Paulson J.C., DeFrees S.A., Zalipsky S., Guo L., and Lefer A.M. (1995) Cardioprotection by liposome-conjugated sialyl Lewis x-oligosaccharide in myocardial ischaemia and reperfusion injury. Cardiovascular Research, 30, 965–974.
   PubMed Web of Science ®Google Scholar
• Muzykantov V.R. (1998) Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy. Pathophysiology, 5, 15–33.
   Google Scholar
• Nakada M.T., Tam S.H., Woulfe D.S., Casper K.A., Swerlick R.A., and Ghrayeb J. (1998) Neutralization of TNF by the antibody cA2 reveals differential regulation of adhesion molecule expression on TNF-activated endothelial cells. Cell Adhesion and Communication, 5, 491–503.
   PubMed Web of Science ®Google Scholar
• Noble K.E., Panayiotidis P., Collins P.W., Hoffbrand A.V., and Yong K.L. (1996) Monocytes induce E-selectin gene expression in endothelial cells: Role of CD11/CD18 and extracellular matrix proteins. European Journal of Immunology, 26, 2944–2951.
   PubMed Web of Science ®Google Scholar
• Oitzinger W., Hofer-Warbinek R., Schmid J.A., Koshelnick Y., Binder B.R., and de Martin R. (2001) Adenovirus-mediated expression of a mutant Ikappa Bkinase 2 inhibits the response of endothelial cells to in?ammatory stimuli. Blood, 97, 1611–1617.
   PubMed Web of Science ®Google Scholar
• Peacock D.J., Banquerigo M.L., and Brahn E. (1992) Angiogenesis inhibition suppresses collagen arthritis. Journal of Experimental Medicine, 175, 1135– 1138.
   PubMed Web of Science ®Google Scholar
• Peacock D.J., Banquerigo M.L., and Brahn E. (1995) A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cellular Immunology, 160, 178–184.
   PubMed Web of Science ®Google Scholar
• Pitzalis C., Pipitone N., Bajocchi G., Hall M., Goulding N., Lee A., Kingsley G., Lanchbury J., and Panayi G. (1997) Corticosteroids inhibit lymphocyte binding to endothelium and intercellular adhesion: An additional mechanism for their anti-in?ammatory and immunosuppressive effect. Journal of Immunology, 158, 5007–5016.
   PubMed Web of Science ®Google Scholar
• Pizcueta P., and Luscinskas F.W. (1994) Monoclonal antibody blockade of L-selectin inhibits mononuclear leukocyte recruitment to in?ammatory sites in vivo. American Journal of Pathology, 145, 461–469.
   PubMed Web of Science ®Google Scholar
• Rensen P.C., de Vrueh R.L., Kuiper J., Bijsterbosch M.K., Biessen E.A., and van Berkel T.J. (2001) Recombinant lipoproteins: Lipoprotein-like lipid particles for drug targeting. Advanced Drug Delivery Reviews, 47, 251–276.
   PubMed Web of Science ®Google Scholar
• Rensen P.C.N., Schiffelers R.M., Versluis A.J., Bijsterbosch M.K., van Kuijk-meuwissen M.E.M.J., and van Berkel T.J.C. (1997) Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-speci?c delivery of antitumor agents. Molecular Pharmacology, 52, 445–455.
   PubMed Web of Science ®Google Scholar
• Ricard I., Payet M.D., and Dupuis G. (1998) VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its alpha 4 beta 1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes. European Journal of Immunology, 28, 1708– 1718.
   PubMed Web of Science ®Google Scholar
• Romero E.L., Morilla M.J., Regts J., Koning G.A., and Scherphof G.L. (1999) On the mechanism of hepatic transendothelial passage of large liposomes. FEBS Letters, 448, 193–196.
   PubMed Web of Science ®Google Scholar
• Schiffelers R.M., Bakker-Woudenberg I.A., Snijders S.V., and Storm G. (1999) Localization of sterically stabilized liposomes in Klebsiella pneumoniaeinfected rat lung tissue: In?uence of liposome characteristics. Biochimica Biophysica Acta, 1421, 329–339.
   PubMed Web of Science ®Google Scholar
• Schiffelers R.M., Storm G., and Bakker-Woudenberg I.A. (2001) Host factors in?uencing the preferential localization of sterically stabilized liposomes in Klebsiella pneumoniae-infected rat lung tissue. Pharmaceutical Research, 18, 780–787.
   PubMed Web of Science ®Google Scholar
• Schimmer R.C., Schrier D.J., Flory C.M., Dykens J., Tung D.K.L., Jacobson P.B., Friedl H.P., Conroy M.C., Schimmer B.B., and Ward P.A. (1997) Streptococcal cell wall-induced arthritis: Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-in?ammatory protein-2. Journal of Immunology, 159, 4103–4108.
   PubMed Web of Science ®Google Scholar
• Selzman C.H., Shames B.D., McIntyre R.C., Banerjee A., and Harken A.H. (1999) The NF kappa B inhibitory peptide, I kappa B alpha, prevents human vascular smooth muscle proliferation. Annals of Thoracic Surgery, 67, 1227–1231.
   PubMed Web of Science ®Google Scholar
• Selzman C.H., Shames B.D., Reznikov L.L., Miller S.A., Meng X.Z., Barton H.A., Werman A., Harken A.H., Dinarello C.A., and Banerjee A. (1999) Liposomal delivery of puri?ed inhibitory-kappa B alpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation. Circulation Research, 84, 867–875.
   PubMed Web of Science ®Google Scholar
• Setiadi H., Disdier M., Green S.A., Canfield W.M., and McEver R.P.. (1995) Residues throughout the cytoplasmic domain affect the internalization ef?ciency of P-selectin. Journal of Biological Chemistry, 270, 26818–26826.
   Google Scholar
• Sfikakis P.P., and Tsokos G.C. (1995) Lymphocyte adhesion molecules in autoimmune rheumatic diseases: Basic issues and clinical expectations. Clinical and Experimental Rheumatology, 13, 763–777.
   PubMed Web of Science ®Google Scholar
• Torchilin V.P., Rammohan R., Weissig V., and Levchenko T.S. (2001) TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proceedings of the National Academy of Sciences USA, 98, 8786–8791.
   PubMed Web of Science ®Google Scholar
• van de Wetering P., Schuurmans-Nieuwenbroek N.M., Hennink W.E., and Storm G. (1999) Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes. Journal of Gene Medicine, 1, 156–165.
   PubMed Web of Science ®Google Scholar
• Whitcup S.M., Chan C.C., Kozhich A.T., and Magone M.T. (1999) Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis. Clinical Immunology, 93, 107–113.
   PubMed Web of Science ®Google Scholar
• Wickham T.J., Haskard D., Segal D., and Kovesdi I. (1997) Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation. Cancer Immunology Immunotherapy, 45, 149–151.
   PubMed Web of Science ®Google Scholar
• Williams R.O., Feldmann M., and Maini R.N. (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences USA, 89, 9784–9788.
   PubMed Web of Science ®Google Scholar
• Worthylake R.A., and Burridge K. (2001) Leukocyte transendothelial migration: Orchastrating the underlying molecular machinery. Current Opinion in Cell Biology, 13, 569–577.
   PubMed Web of Science ®Google Scholar
• Yusuf-Makagiansar H., and Siahaan T.J. (2001) Binding and internalization of an LFA-1-derived cyclic peptide by ICAM receptors on activated lymphocyte: A potential ligand for drug targeting to ICAM-1-expressing cells. Pharmaceutical Research, 18, 329–335.
   PubMed Web of Science ®Google Scholar